← All science articles

· 2 min read

Cystamine Shows Mixed Results Against Radiation Damage in Rat Blood Cells

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

This 1985 study, published in Radiobiologiia by Pechenina and colleagues, looked at how radiation damages the genetic material inside white blood cells, and whether a protective chemical called cystamine could help.

The researchers exposed rats to ionizing radiation, in some cases combined with heat exposure, and measured levels of polydeoxyribonucleotide (PDN) — a breakdown product of chromatin, the DNA-protein material inside cell nuclei — in their white blood cells. They found that PDN levels in the blood tracked closely with how severe the radiation sickness was and how the animals fared afterward, making it a kind of biological marker of damage.

When cystamine was given beforehand to protect against the combined radiation-and-heat injury, it lowered the PDN levels in white blood cells. However, this reduction did not translate into better survival — the treated and untreated animals survived at similar rates. The abstract gives no numbers, sample sizes, or statistical detail, so the strength and reproducibility of these findings cannot be judged from this record alone. It also does not describe PDN as an administered substance, only as a marker measured in the animals' blood.

Our reflection

This paper sits far from today's skin and tissue applications of PDRN, but it is part of the decades-long record of scientists tracking what happens to DNA fragments in the body under stress. At Havdis, we see this kind of basic radiobiology as part of the long groundwork that eventually let researchers understand polydeoxyribonucleotides well enough to put them to more constructive use.

Source

Pechenina NA, Riabchenko NI, Budagov RS (1985). Radiobiologiia.

Read the paper on PubMed

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.